ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,372, issued on April 21, was assigned to Celgene Corp. (Summit, N.J.).
"Combination therapy for the treatment of cancer" was invented by Michael D. Amatangelo (Madison, N.J.), Chad Bjorklund (Summit, N.J.), Anjan Thakurta (Basking Ridge, N.J.), Xiankang Hong (Bridgewater, N.J.) and Mariana Cota (Summit, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating and/or managing cancers, which comprise administering to a patient Compound A, or an enantiomer or a mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof in combination with darat...